Table 3.
Metabolites displaying trends toward different plasma concentrations in Alzheimer’s patients (AD) and control subjects*.
| AD | Control | P-value | |
|---|---|---|---|
| Postprandial | |||
| Behenic (docosanoic) acid | 959 ± 116 | 759 ± 234 | 0.046 |
| Linoleic acid | 619 ± 218 | 925 ± 273 | 0.026 |
| Oleic acid | 1597 ± 683 | 2577 ± 1124 | 0.05 |
| Cystine | 14343 ± 2768 | 10214 ± 4575 | 0.043 |
| Taurine | 846 ± 328 | 461 ± 362 | 0.044 |
| Fasting | |||
| Phosphoric acid | 74528 ± 8966 | 88939 ± 8020 | 0.0058 |
| Glyoxalurea | 1555 ± 281 | 1900 ± 254 | 0.025 |
| Fructose | 2215 ± 670 | 1471 ± 408 | 0.029 |
*
Data are expressed as means ± SD. P-values determined by t-test and reported for those metabolites with p ≤ 0.05 compared to control. After controlling for false discovery rate, none of the metabolites were shown to be significantly different between groups.